Emmaus Life Sciences Announces Submission of Marketing Authorization Application to Swissmedic Ideogen, A.G. to Manage Early Access Program Jun 15, 2021 11:21am EDT
Emmaus Life Sciences Announces Submission of Marketing Authorization Application for Endari® to the Saudi Food & Drug Authority May 26, 2021 12:19pm EDT
Emmaus Life Sciences Reports Annual Financial Results for 2020 and Provides Updated Business Review May 04, 2021 9:30am EDT
Emmaus Life Sciences Announces Collaboration with Kainos Medicine for Preclinical Development of IRAK4 Inhibitor as Potential Anti-Cancer Drug Mar 02, 2021 11:44am EST
Emmaus Life Sciences Reports Annual Financial Results for 2019 and Provides Business Review Jan 25, 2021 12:13pm EST
